{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T17:11:55Z","timestamp":1774717915848,"version":"3.50.1"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science","award":["0088\/DIA\/2020\/49"],"award-info":[{"award-number":["0088\/DIA\/2020\/49"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Epilepsy is a prevalent neurological condition marked by seizures that lead to neurobiological and behavioral impairments. Caffeine (CAF), the world\u2019s most consumed stimulant, reportedly affects both epileptic seizures and the efficacy of antiepileptic drugs, particularly topiramate (TPM). This study aimed to investigate the effects of CAF on TPM in a pentylenetetrazol (PTZ)-induced seizure model using zebrafish larvae. Four days post-fertilization <jats:italic>Danio rerio<\/jats:italic> larvae were incubated for 18 hours with CAF, TPM, or CAF+TPM, followed by an assessment of locomotor activity. Seizures were induced by adding PTZ to achieve a final concentration of 20\u2009mM. In the PTZ-induced seizure model, the application of CAF in doses over 50\u2009mg\/L resulted in a decrease in the average movement. TPM ( &gt; 50 \u03bcM) significantly protected larvae against the PTZ. The addition of 15\u2009mg\/L CAF to TPM did not affect larval activity at any TPM concentration tested; however, higher doses of CAF significantly reduced larval activity. CAF doses above 25\u2009mg\/L altered the activity of larvae treated with TPM in the PTZ-induced seizure model. Larvae exhibited differential heart rate (HR) responses to CAF exposure across doses. CAF at 75\u2009mg\/L significantly increased HR, while doses of 175\u2009mg\/L and higher induced bradycardia. TPM, across all tested doses, did not independently influence HR. The study provides valuable insights into the interactions between CAF and TPM, which may inform future research on human epilepsy. However, the extrapolation of these results to other species should be approached cautiously due to physiological differences.<\/jats:p>","DOI":"10.1371\/journal.pone.0317241","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:24:36Z","timestamp":1741112676000},"page":"e0317241","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of caffeine modulation of topiramate effect on locomotor activity of zebrafish larvae in pentylenetetrazol-induced seizure model"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6840-7320","authenticated-orcid":true,"given":"Adrian","family":"Bartoszek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-0706","authenticated-orcid":true,"given":"Emilia","family":"Fornal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"6","key":"pone.0317241.ref001","doi-asserted-by":"crossref","first-page":"a022426","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: an overview for neuroscientists","volume":"5","author":"CE Stafstrom","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"pone.0317241.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42494-021-00055-z","article-title":"The pharmacological treatment of epilepsy: recent advances and future perspectives","volume":"3","author":"E Perucca","year":"2021","journal-title":"Acta Epileptologica"},{"key":"pone.0317241.ref003","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2147\/NDT.S256699","article-title":"Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies","volume":"17","author":"D Guery","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"pone.0317241.ref004","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3945\/ajcn.113.080077","article-title":"Trends in intake and sources of caffeine in the diets of US adults: 2001-2010","volume":"101","author":"VL Fulgoni","year":"2015","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"pone.0317241.ref005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11910-019-0948-5","article-title":"The Use of Caffeine by People with Epilepsy: the Myths and the Evidence","volume":"19","author":"PR Bauer","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"pone.0317241.ref006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1734-1140(11)70394-2","article-title":"Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data","volume":"63","author":"M Chro\u015bci\u0144ska-Krawczyk","year":"2011","journal-title":"Pharmacol Rep"},{"key":"pone.0317241.ref007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yebeh.2017.11.003","article-title":"Caffeine and seizures: A systematic review and quantitative analysis","volume":"80","author":"RR van Koert","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"7446","key":"pone.0317241.ref008","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"K Howe","year":"2013","journal-title":"Nature"},{"issue":"6","key":"pone.0317241.ref009","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1089\/zeb.2016.1313","article-title":"Pharmacokinetic Modeling of Paracetamol Uptake and Clearance in Zebrafish Larvae: Expanding the Allometric Scale in Vertebrates with Five Orders of Magnitude","volume":"13","author":"V Kantae","year":"2016","journal-title":"Zebrafish"},{"issue":"13","key":"pone.0317241.ref010","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5694\/j.1326-5377.1960.tb73127.x","article-title":"The Principles of Humane Experimental Technique","volume":"1","year":"1960","journal-title":"Medical Journal of Australia"},{"key":"pone.0317241.ref011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnmol.2016.00055","article-title":"Function Over Form: Modeling Groups of Inherited Neurological Conditions in Zebrafish","volume":"9","author":"RA Kozol","year":"2016","journal-title":"Front Mol Neurosci"},{"issue":"Pt 8","key":"pone.0317241.ref012","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1093\/brain\/awu147","article-title":"On the modelling of seizure dynamics","volume":"137","author":"KJ Friston","year":"2014","journal-title":"Brain"},{"key":"pone.0317241.ref013","doi-asserted-by":"crossref","first-page":"4","DOI":"10.20517\/2572-8180.2017.15","article-title":"Zebrafish as screening model for detecting toxicity and drugs efficacy","volume":"3","author":"MV Caballero","year":"2018","journal-title":"J Unexplored Med Data"},{"issue":"10","key":"pone.0317241.ref014","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd4627","article-title":"Zebrafish as tools for drug discovery","volume":"14","author":"CA MacRae","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"pone.0317241.ref015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/35047564","article-title":"Zebrafish genetics and vertebrate heart formation","volume":"2","author":"DY Stainier","year":"2001","journal-title":"Nat Rev Genet"},{"issue":"10","key":"pone.0317241.ref016","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.3390\/ijms19103195","article-title":"Zinc Chloride Exposure Inhibits Brain Acetylcholine Levels, Produces Neurotoxic Signatures, and Diminishes Memory and Motor Activities in Adult Zebrafish","volume":"19","author":"S Sarasamma","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"12","key":"pone.0317241.ref017","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3390\/ijms17122123","article-title":"Zebrafish as a Vertebrate Model System to Evaluate Effects of Environmental Toxicants on Cardiac Development and Function","volume":"17","author":"S Sarmah","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0317241.ref018","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acs.chemrestox.9b00335","article-title":"Use of Zebrafish in Drug Discovery Toxicology","volume":"33","author":"S Cassar","year":"2020","journal-title":"Chem Res Toxicol"},{"key":"pone.0317241.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2020.06.010","article-title":"Seizing the moment: Zebrafish epilepsy models","author":"K Gawel","year":"2020","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"1","key":"pone.0317241.ref020","doi-asserted-by":"crossref","first-page":"e54166","DOI":"10.1371\/journal.pone.0054166","article-title":"Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs","volume":"8","author":"T Afrikanova","year":"2013","journal-title":"PLoS One"},{"key":"pone.0317241.ref021","volume-title":"The zebrafish book: A guide for the laboratory use of zebrafish (Danio rerio)","author":"M Westerfield","year":"2000"},{"issue":"1","key":"pone.0317241.ref022","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2011.11.041","article-title":"On the edge: pharmacological evidence for anxiety-related behavior in zebrafish larvae","volume":"228","author":"H Richendrfer","year":"2012","journal-title":"Behav Brain Res"},{"issue":"12","key":"pone.0317241.ref023","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/dneu.20741","article-title":"Glutamate drives the touch response through a rostral loop in the spinal cord of zebrafish embryos","volume":"69","author":"T Pietri","year":"2009","journal-title":"Dev Neurobiol"},{"key":"pone.0317241.ref024","doi-asserted-by":"crossref","first-page":"112695","DOI":"10.1016\/j.biopha.2022.112695","article-title":"Pharmacological assessment of zebrafish-based cardiotoxicity models","volume":"148","author":"M Maciag","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"pone.0317241.ref025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuro.2008.09.011","article-title":"Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol","volume":"30","author":"RC MacPhail","year":"2009","journal-title":"Neurotoxicology"},{"key":"pone.0317241.ref026","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pbb.2016.03.010","article-title":"Anxiety-related behavioral responses of pentylenetetrazole-treated zebrafish larvae to light-dark transitions","volume":"145","author":"X Peng","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"pone.0317241.ref027","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11419-021-00577-8","article-title":"Caffeine-induced bradycardia, death, and anxiety-like behavior in zebrafish larvae","volume":"39","author":"H Maeda","year":"2021","journal-title":"Forensic Toxicol"},{"issue":"10","key":"pone.0317241.ref028","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.0000061912.88753.87","article-title":"Drugs that induce repolarization abnormalities cause bradycardia in zebrafish","volume":"107","author":"DJ Milan","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"pone.0317241.ref029","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/zeb.2009.0631","article-title":"Caffeine-induced effects on heart rate in zebrafish embryos and possible mechanisms of action: an effective system for experiments in chemical biology","volume":"7","author":"N Rana","year":"2010","journal-title":"Zebrafish"},{"issue":"2","key":"pone.0317241.ref030","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1124\/jpet.105.094755","article-title":"Direct block of human ether-a-go-go-related gene potassium channels by caffeine","volume":"316","author":"SL Cockerill","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"pone.0317241.ref031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eplepsyres.2004.10.002","article-title":"Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents","volume":"63","author":"BR Danielsson","year":"2005","journal-title":"Epilepsy Res"},{"issue":"2","key":"pone.0317241.ref032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/00912700222011157","article-title":"Clinical pharmacology: drugs as a benefit and\/or risk in sudden unexpected death in epilepsy?","volume":"42","author":"CM Lathers","year":"2002","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"pone.0317241.ref033","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.2018-01010","article-title":"Cardiovascular Safety During and After Use of Phentermine and Topiramate","volume":"104","author":"ME Ritchey","year":"2018","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"pone.0317241.ref034","first-page":"297","article-title":"The effect of topiramate on weight loss in patients with type 2 diabetes","volume":"18","author":"S Moradi","year":"2013","journal-title":"J Res Med Sci"},{"issue":"1\u20132","key":"pone.0317241.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.01.083","article-title":"Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review","volume":"101","author":"M Rivera-Oliver","year":"2014","journal-title":"Life Sci"},{"issue":"4","key":"pone.0317241.ref036","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1471-4159.2005.03259.x","article-title":"Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures","volume":"94","author":"M Angehagen","year":"2005","journal-title":"J Neurochem"},{"issue":"1","key":"pone.0317241.ref037","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1535-7597.2004.04107.x","article-title":"GluR5 Kainate Receptors and Topiramate: A New Site of Action for Antiepileptic Drugs?","volume":"4","author":"FE Dudek","year":"2004","journal-title":"Epilepsy Curr"},{"issue":"1","key":"pone.0317241.ref038","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2011.03.025","article-title":"Patterns of avoidance behaviours in the light\/dark preference test in young juvenile zebrafish: a pharmacological study","volume":"222","author":"PJ Steenbergen","year":"2011","journal-title":"Behav Brain Res"},{"key":"pone.0317241.ref039","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cbpc.2017.01.007","article-title":"Effects of caffeine on behavioral and inflammatory changes elicited by copper in zebrafish larvae: Role of adenosine receptors","volume":"194","author":"FF Cruz","year":"2017","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"12","key":"pone.0317241.ref040","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1080\/10934529.2021.1989931","article-title":"Neuromotor activity inhibition in zebrafish early-life stages after exposure to environmental relevant concentrations of caffeine","volume":"56","author":"NO de Farias","year":"2021","journal-title":"J Environ Sci Health A Tox Hazard Subst Environ Eng"},{"issue":"3","key":"pone.0317241.ref041","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1742-7843.2011.00710.x","article-title":"Adenosine A1, but not A2, receptor blockade increases anxiety and arousal in Zebrafish","volume":"109","author":"C Maximino","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"pone.0317241.ref042","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbr.2009.06.022","article-title":"Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish","volume":"205","author":"RJ Egan","year":"2009","journal-title":"Behav Brain Res"},{"issue":"2","key":"pone.0317241.ref043","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbr.2009.12.023","article-title":"Analyzing habituation responses to novelty in zebrafish (Danio rerio)","volume":"208","author":"K Wong","year":"2010","journal-title":"Behav Brain Res"},{"issue":"2","key":"pone.0317241.ref044","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002130050037","article-title":"The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists","volume":"148","author":"M El Yacoubi","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"pone.0317241.ref045","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0278-6915(02)00096-0","article-title":"Effects of caffeine on human behavior","volume":"40","author":"A Smith","year":"2002","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"pone.0317241.ref046","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0091-3057(88)90179-7","article-title":"Tolerance to behavioral effects of caffeine in rats","volume":"29","author":"SG Holtzman","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"pone.0317241.ref047","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.68341","article-title":"Caffeine Dose-Response Relationship and Behavioral Screening in Zebrafish","author":"LC Santos","year":"2017","journal-title":"The Question of Caffeine"},{"issue":"5","key":"pone.0317241.ref048","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ntt.2008.04.003","article-title":"Movement disorder and neuromuscular change in zebrafish embryos after exposure to caffeine","volume":"30","author":"Y-H Chen","year":"2008","journal-title":"Neurotoxicol Teratol"},{"issue":"5","key":"pone.0317241.ref049","doi-asserted-by":"crossref","first-page":"e0125898","DOI":"10.1371\/journal.pone.0125898","article-title":"Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine","volume":"10","author":"Y Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pone.0317241.ref050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2007.03.015","article-title":"Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants","volume":"75","author":"S Berghmans","year":"2007","journal-title":"Epilepsy Res"},{"key":"pone.0317241.ref051","doi-asserted-by":"crossref","first-page":"836573","DOI":"10.3389\/fphar.2022.836573","article-title":"Neural Activity Correlates With Behavior Effects of Anti-Seizure Drugs Efficacy Using the Zebrafish Pentylenetetrazol Seizure Model","volume":"13","author":"PC Milder","year":"2022","journal-title":"Front Pharmacol"},{"key":"pone.0317241.ref052","doi-asserted-by":"crossref","first-page":"115655","DOI":"10.1016\/j.taap.2021.115655","article-title":"Effects of new antiseizure drugs on seizure activity and anxiety-like behavior in adult zebrafish","volume":"427","author":"M Pier\u00f3g","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"pone.0317241.ref053","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/epi.13476","article-title":"Acute cognitive impact of antiseizure drugs in naive rodents and corneal-kindled mice","volume":"57","author":"ML Barker-Haliski","year":"2016","journal-title":"Epilepsia"},{"key":"pone.0317241.ref054","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2016.03.004","article-title":"Involvement of NMDA receptors and L-arginine\/nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test","volume":"122","author":"S Ostadhadi","year":"2016","journal-title":"Brain Res Bull"},{"issue":"1","key":"pone.0317241.ref055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/0971-5916.193296","article-title":"Effect of lamotrigine, levetiracetam & topiramate on neurobehavioural parameters & oxidative stress in comparison with valproate in rats","volume":"144","author":"SC Sarangi","year":"2016","journal-title":"Indian J Med Res"},{"issue":"2","key":"pone.0317241.ref056","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yebeh.2005.04.013","article-title":"Motor performance and behavior of immature rats are not compromised by a high dose of topiramate","volume":"7","author":"M Alaverdashvili","year":"2005","journal-title":"Epilepsy Behav"},{"key":"pone.0317241.ref057","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.seizure.2017.09.015","article-title":"Behavioral effects of antiepileptic drugs in rats: Are the effects on mood and behavior detectable in open-field test?","volume":"52","author":"E Zimcikova","year":"2017","journal-title":"Seizure"},{"issue":"2","key":"pone.0317241.ref058","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1528-1157.1994.tb02459.x","article-title":"Topiramate: preclinical evaluation of structurally novel anticonvulsant","volume":"35","author":"RP Shank","year":"1994","journal-title":"Epilepsia"},{"issue":"5","key":"pone.0317241.ref059","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1059-1311(03)00185-7","article-title":"Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models","volume":"13","author":"GJ Sills","year":"2004","journal-title":"Seizure"},{"issue":"3","key":"pone.0317241.ref060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1254\/jphs.09225FP","article-title":"Effects of antiepileptics on behavioral and electroencephalographic seizure induced by pentetrazol in mice","volume":"112","author":"Y Watanabe","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"pone.0317241.ref061","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/B978-012088554-1\/50017-7","article-title":"Modeling Epilepsy and Seizures in Developing Zebrafish Larvae","author":"SC Baraban","year":"2006","journal-title":"Models of Seizures and Epilepsy"},{"issue":"4","key":"pone.0317241.ref062","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.pharep.2016.03.011","article-title":"Influence of caffeine on the protective activity of gabapentin and topiramate in a mouse model of generalized tonic-clonic seizures","volume":"68","author":"M Jargie\u0142\u0142o-Baszak","year":"2016","journal-title":"Pharmacol Rep"},{"issue":"1","key":"pone.0317241.ref063","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1528-1157.1981.tb04335.x","article-title":"Caffeine- and aminophylline-induced seizures","volume":"22","author":"NS Chu","year":"1981","journal-title":"Epilepsia"},{"issue":"4","key":"pone.0317241.ref064","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/phrs.1997.0124","article-title":"A pharmacological and clinical review on topiramate, a new antiepileptic drug","volume":"35","author":"E Perucca","year":"1997","journal-title":"Pharmacol Res"},{"issue":"19","key":"pone.0317241.ref065","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2174\/138161210791516404","article-title":"Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients","volume":"16","author":"BA Johnson","year":"2010","journal-title":"Curr Pharm Des"},{"key":"pone.0317241.ref066","first-page":"291","volume-title":"Illustrated Zebrafish Neurobehavioral glossary","author":"AV Kalueff","year":"2017"},{"issue":"3","key":"pone.0317241.ref067","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1533-2500.2004.04304.x","article-title":"Side effects of antiepileptics--a review","volume":"4","author":"KS Walia","year":"2004","journal-title":"Pain Pract"},{"issue":"4","key":"pone.0317241.ref068","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1734-1140(13)71060-0","article-title":"Research advances in basic mechanisms of seizures and antiepileptic drug action","volume":"65","author":"W Laso\u0144","year":"2013","journal-title":"Pharmacol Rep"},{"issue":"1","key":"pone.0317241.ref069","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/jpet.119.260299","article-title":"Mechanistic and Quantitative Understanding of Pharmacokinetics in Zebrafish Larvae through Nanoscale Blood Sampling and Metabolite Modeling of Paracetamol","volume":"371","author":"RC Van Wijk","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"s1","key":"pone.0317241.ref070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action","volume":"41","author":"RP Shank","year":"2000","journal-title":"Epilepsia"},{"issue":"8","key":"pone.0317241.ref071","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1172\/JCI65636","article-title":"Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis","volume":"123","author":"RL Williams-Karnesky","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0317241.ref072","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.forsciint.2005.04.016","article-title":"Fatal caffeine overdose: two case reports","volume":"153","author":"S Kerrigan","year":"2005","journal-title":"Forensic Sci Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:25:00Z","timestamp":1741112700000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317241"}},"subtitle":[],"editor":[{"given":"Ahmed E.","family":"Abdel Moneim","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":72,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0317241","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]}}}